Award details

Mechanistic and structural analysis of topo IV and gyrase and their targeting by antibacterial quinolones

Reference	BB/H00405X/1
Principal Investigator / Supervisor	Professor Larry Mark Fisher
Co-Investigators / Co-Supervisors	Dr Mark Sanderson
Institution	St George's University of London
Department	Basic Medical Sciences
Funding type	Research
Value (£)	620,906
Status	Completed
Type	Research Grant
Start date	01/09/2009
End date	31/08/2012
Duration	36 months

Abstract

Topo IV and DNA gyrase regulate DNA supercoiling and chromosome segregation and are important targets of antibacterial quinolones used against Streptococcus pneumoniae and other Gram-positive organisms. Both enzymes act by passing a DNA duplex through a transient double-stranded break in a 'gate' or G-duplex involving formation of a transient covalent enzyme-DNA intermediate known as the 'cleavage complex'. In a very important advance, we recently solved the crystal structure of cleavage complexes formed by the topo IV ParC breakage-reunion- and ParE metal binding (TOPRIM) domains in complex with a G-DNA gate stabilised by moxifloxacin and clinafloxacin, two antipneumococcal fluoroquinolones. The structure suggests how the DNA G-gate may operate in tandem with N- and C- protein gates to facilitate DNA transport, and moreover provides a wealth of drug-enzyme-DNA information to guide drug design. We aim to test a number of hypotheses relating to how ParE interacts with ParC, DNA or ATP to coordinate gate recognition and opening. In addition, a combination of biochemical, structural and chemical approaches will be used to investigate novel topo IV inhibitors engineered to have greater potency, that target topo IV and gyrase equally (dual action to minimise development of resistance) or act irreversibly (to reduce resistance). Completion of the work will provide new insights on the reaction cycle of topo IV and gyrase and their interactions with novel antibacterial drugs.

Summary

Topo IV and gyrase are enzymes that untangle bacterial chromosomes and are important targets of anti-infective drugs. Both enzymes make a DNA break (known as a 'gate') in one DNA molecule and pass a second DNA helix through the gate. Quinolone drugs kill bacteria by stabilizing the enzyme-opened gate. This project aims to understand how topo IV and gyrase mediate gate opening and closure, and how drugs interfere with these fundamental processes. The study builds on insights gained from our recent X-ray crystal structure that revealed how quinolones act at the topo IV-DNA gate. This structure provides a number of intriguing mechanistic hypotheses to be tested and paves the way for the design and evaluation of new inhibitors with novel modes of action that should minimize the emergence of drug resistance.

Committee	Research Committee D (Molecules, cells and industrial biotechnology)
Research Topics	Microbiology, Pharmaceuticals, Structural Biology
Research Priority	X – Research Priority information not available
Research Initiative	X - not in an Initiative
Funding Scheme	X – not Funded via a specific Funding Scheme

I accept the terms and conditions of use (opens in new window)

export PDF file

back to list new search